EUVIMEDEUVIMED entdecken
KohortenstudieStudienprotokollOpen Access

Molecular and Pharmacogenetic marker evaluation in relation to the toxicity and clinical response of acute lymphoblastic leukemia treatment in Indian children (MPGx-INDALL) – A Prospective observational cohort study protocol (Preprint)

Swetambri Sharma iD, Shuvadeep Ganguly iD, Kamali Murugadoss iD, Smita Kayal iD, Swaminathan Keerthivasagam iD, Jaikumar Ramamoorthy, Archna Singh iD, Deepam Pushpam iD, Jayanthi Mathaiyan iD, Yvonne Gloor iD, Frederic Baleydier iD, Marc Ansari iD und 3 weitere

JMIR Research Protocols · 2025

DOI: 10.2196/79865 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift JMIR Research Protocols, 2025. Verfasst von Swetambri Sharma und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Swiss National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precursor Cell Lymphoblastic Leukemia-LymphomaAdolescentChildChild, PreschoolFemaleHumansInfantMaleCohort StudiesIndiaObservational Studies as TopicPharmacogeneticsProspective StudiesQuality of LifeTreatment Outcome

Stichwörter der Autor:innen

ICiCLeacute lymphoblastic leukemiagermline variantspediatric ALLpharmacogeneticsquality of lifesequencingsomatic variantstoxicitytreatment-related toxicity

Autor:innen und Institutionen

  • Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research, Dhanvantri Nagar, Puducherry, 605006, India, 91 7675935408.
  • Department of Pediatrics, Jawaharlal Institute of Post Graduate Medical Education and Research, Puducherry, India.
  • Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Pharmacology, Jawaharlal Institute of Post Graduate Medical Education and Research, Puducherry, India.
  • Department of Pediatrics, Gynecology and Obstetrics, CANSEARCH Research Platform in Pediatric Oncology and Haematology, University of Geneva, Geneva, Switzerland.

ORCID-Profile: Swetambri Sharma, Shuvadeep Ganguly, Kamali Murugadoss, Smita Kayal, Swaminathan Keerthivasagam, Archna Singh, Deepam Pushpam, Jayanthi Mathaiyan, Yvonne Gloor, Frederic Baleydier, Marc Ansari, Sameer Bakhshi, Biswajit Dubashi, Chakradhara Rao S Uppugunduri

Förderung

  • Swiss National Science Foundation

Zitieren

APA

Sharma, S., Ganguly, S., Murugadoss, K., Kayal, S., Keerthivasagam, S., Ramamoorthy, J., Singh, A., Pushpam, D., Mathaiyan, J., Gloor, Y., Baleydier, F., Ansari, M., Bakhshi, S., Dubashi, B., & Uppugunduri, C. R. S. (2025). Molecular and Pharmacogenetic marker evaluation in relation to the toxicity and clinical response of acute lymphoblastic leukemia treatment in Indian children (MPGx-INDALL) – A Prospective observational cohort study protocol (Preprint). JMIR Research Protocols. https://doi.org/10.2196/79865

Vancouver

Sharma S, Ganguly S, Murugadoss K, Kayal S, Keerthivasagam S, Ramamoorthy J, et al. Molecular and Pharmacogenetic marker evaluation in relation to the toxicity and clinical response of acute lymphoblastic leukemia treatment in Indian children (MPGx-INDALL) – A Prospective observational cohort study protocol (Preprint). JMIR Research Protocols. 2025. doi:10.2196/79865

BibTeX
@article{Sharma2025,
  author = {Sharma, Swetambri and Ganguly, Shuvadeep and Murugadoss, Kamali and Kayal, Smita and Keerthivasagam, Swaminathan and Ramamoorthy, Jaikumar and Singh, Archna and Pushpam, Deepam and Mathaiyan, Jayanthi and Gloor, Yvonne and Baleydier, Frederic and Ansari, Marc and Bakhshi, Sameer and Dubashi, Biswajit and Uppugunduri, Chakradhara Rao S},
  title = {Molecular and Pharmacogenetic marker evaluation in relation to the toxicity and clinical response of acute lymphoblastic leukemia treatment in Indian children (MPGx-INDALL) – A Prospective observational cohort study protocol (Preprint)},
  journal = {JMIR Research Protocols},
  year = {2025},
  doi = {10.2196/79865}
}
Kostenlos starten →